ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,290 | -29.5% | 10,500 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $14,595 | -12.6% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $16,695 | +26400.0% | 10,500 | +3.8% | 0.00% | -75.0% |
| Q4 2022 | $63 | -99.9% | 10,114 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | +6.2% | 10,114 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $64,000 | +36.2% | 10,114 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $47,000 | -7.8% | 10,114 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $51,000 | +2450.0% | 10,114 | +10014.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |